Clinical Effect of Hibiscus taiwanensis Extract on Women with Genitourinary Syndrome of Menopause.

IF 1.2 Q3 OBSTETRICS & GYNECOLOGY

Journal of Mid-life Health Pub Date : 2025-01-01 Epub Date: 2025-04-05 DOI:10.4103/jmh.jmh_138_24

Cheng-Yu Long, Kun-Ling Lin, Jian-Lin Yeh, Chien-Wei Feng, Zi-Xi Loo

{"title":"Clinical Effect of Hibiscus taiwanensis Extract on Women with Genitourinary Syndrome of Menopause.","authors":"Cheng-Yu Long, Kun-Ling Lin, Jian-Lin Yeh, Chien-Wei Feng, Zi-Xi Loo","doi":"10.4103/jmh.jmh_138_24","DOIUrl":null,"url":null,"abstract":"Objective: The deficiency of estrogen becomes clinically more overt over time and correlated with amounts of genitourinary syndromes of menopause (GSM). Our study aimed at examining the clinical effect of Hibiscus taiwanensis compound extract (HERCET®-w gel) on women with GSM.Subjects and methods: This study included 31 patients with GSM symptoms. The treatment administered to patients included in this study was the daily use of vaginal treatment of HERCET®-w gel. Before, 3 months, and 6 months after HERCET®-w gel treatment, each patient's baseline characteristic data were collected.Results: Our data showed that HERCET®-w gel could significantly improve some index or questionnaire in urinary symptoms including the Urogenital Distress Inventory 6, the Vaginal Health Index, or pH value. It also showed a significant increase in sexual function after 6 months treatment of HERCET®-w.Conclusion: HERCET®-w on the women with GSM after 6 months could significantly improve GSM. It also showed an obvious progress of patients' sexual function in the Female Sexual Function Index score in the 6-month follow-up.","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":"16 1","pages":"60-66"},"PeriodicalIF":1.2000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12052280/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Mid-life Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jmh.jmh_138_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The deficiency of estrogen becomes clinically more overt over time and correlated with amounts of genitourinary syndromes of menopause (GSM). Our study aimed at examining the clinical effect of Hibiscus taiwanensis compound extract (HERCET®-w gel) on women with GSM.

Subjects and methods: This study included 31 patients with GSM symptoms. The treatment administered to patients included in this study was the daily use of vaginal treatment of HERCET®-w gel. Before, 3 months, and 6 months after HERCET®-w gel treatment, each patient's baseline characteristic data were collected.

Results: Our data showed that HERCET®-w gel could significantly improve some index or questionnaire in urinary symptoms including the Urogenital Distress Inventory 6, the Vaginal Health Index, or pH value. It also showed a significant increase in sexual function after 6 months treatment of HERCET®-w.

Conclusion: HERCET®-w on the women with GSM after 6 months could significantly improve GSM. It also showed an obvious progress of patients' sexual function in the Female Sexual Function Index score in the 6-month follow-up.

查看原文本刊更多论文

台湾芙蓉提取物治疗绝经期泌尿生殖系统综合征的临床疗效观察。

目的：雌激素缺乏在临床上随着时间的推移变得更加明显，并与绝经期泌尿生殖系统综合征（GSM）的数量相关。本研究旨在探讨台湾芙蓉提取物（HERCET®-w凝胶）对女性GSM的临床疗效。对象和方法：本研究纳入31例有GSM症状的患者。在这项研究中，患者接受的治疗是每天使用阴道治疗HERCET®-w凝胶。在HERCET®-w凝胶治疗前、3个月和6个月后，收集每位患者的基线特征数据。结果：我们的数据显示，HERCET®-w凝胶可以显著改善泌尿系统症状的一些指标或问卷，包括泌尿生殖窘迫量表6、阴道健康指数或pH值。HERCET®-w治疗6个月后，性功能也有显著提高。结论：HERCET®-w治疗6个月后可显著改善GSM。在随访6个月的女性性功能指数评分中，患者的性功能也有明显改善。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Mid-life Health Social Sciences-Health (social science)

CiteScore

1.70

自引率

9.10%

发文量

审稿时长

43 weeks

期刊介绍： Journal of mid-life health is the official journal of the Indian Menopause society published Quarterly in January, April, July and October. It is peer reviewed, scientific journal of mid-life health and its problems. It includes all aspects of mid-life health, preventive as well as curative. The journal publishes on subjects such as gynecology, neurology, geriatrics, psychiatry, endocrinology, urology, andrology, psychology, healthy ageing, cardiovascular health, bone health, quality of life etc. as relevant of men and women in their midlife. The Journal provides a visible platform to the researchers as well as clinicians to publish their experiences in this area thereby helping in the promotion of mid-life health leading to healthy ageing, growing need due to increasing life expectancy. The Editorial team has maintained high standards and published original research papers, case reports and review articles from the best of the best contributors both national & international, consistently so that now, it has become a great tool in the hands of menopause practitioners.